Compound ID | 1353
Class: Drug combination: beta-lactam + beta-lactamase inhibitor
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Combination treatment. |
Institute where first reported: | Novartis |
Highest developmental phase: | Preclinical |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/140855264 |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/43672 |
Citations: |
|